(Q43851385)

27 November 2017

title

Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function (English)

1 reference

27 November 2017

1 reference

Joseph A Hill

1

1 reference

27 November 2017

Beverly Rothermel

2

1 reference

27 November 2017

Ki-Dong Yoo

3

1 reference

27 November 2017

Barry Cabuay

4

1 reference

27 November 2017

Elaine Demetroulis

5

1 reference

27 November 2017

Robert M Weiss

6

1 reference

27 November 2017

William Kutschke

7

1 reference

27 November 2017

Rhonda Bassel-Duby

8

1 reference

27 November 2017

R Sanders Williams

9

1 reference

27 November 2017

language of work or name

English

0 references

publication date

10 January 2002

1 reference

Journal of Biological Chemistry

27 November 2017

published in

1 reference

27 November 2017

volume

277

1 reference

27 November 2017

issue

12

1 reference

27 November 2017

page(s)

10251-10255

1 reference

Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110722200

Cytoplasmic signaling pathways that regulate cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110722200

Na+-Ca2+ exchanger remodeling in pressure overload cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110722200

An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110722200

A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110722200

Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110722200

Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110722200

Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110722200

Calcineurin inhibition and cardiac hypertrophy: a matter of balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110722200

Calcineurin inhibition in hypertrophy: back from the dead!

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110722200

Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110722200

CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110722200

Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110722200

gp130 plays a critical role in pressure overload-induced cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110722200

Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110722200

21 January 2018

Identifiers

DOI

10.1074/JBC.M110722200

1 reference

27 November 2017

1 reference